Core Scientific第四季度调整后每股亏损$(0.13) 超出$(0.08)预期,销售额为$94.92M 不及预期$99.92M

财报速递2025-02-27
Core Scientific(纳斯达克股票代码:CORZ)报告的季度每股亏损为$(0.13),比分析师一致预期的$(0.08)低62.5%。这比去年同期每股亏损$(0.51)增加了74.51%。公司报告的季度销售额为$94.92M,比分析师一致预期的$99.92M低5%。这比去年同期的$141.93M下降了33.12%。

以上内容来自Benzinga Earnings专栏,原文如下:

Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 62.5 percent. This is a 74.51 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $94.92 million which missed the analyst consensus estimate of $99.92 million by 5.00 percent. This is a 33.12 percent decrease over sales of $141.93 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法